Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

IP Updates

Boston Breakfast Series - Biotech & Pharma Issues

June 9, 2011

IP Updates

Boston Breakfast Series - Biotech & Pharma Issues

June 9, 2011

Back to News Listing

Fish & Richardson “Boston Breakfast Series” seminars focus on topics trending in the biotech and pharmaceutical industries. To learn more about the series, please contact us.

Next Seminar:

7/16/2014
Patents – Just the BasicsSpeakers: Jay Kugler DeYoung and Tiffany Reiter, PhD
View Description

Recent Seminars:

5/21/2014
The USPTO Extends its Ability to Limit Examination of Markush ClaimsSpeaker: Christine A. Goddard, Ph.D.
View Description
3/26/2014
The USTPO Expands (Really Expands!) on MyriadSpeaker: Mark S. Ellinger, Ph.D.
View Description
1/15/2014
Biotech and Pharma Patents at the Supreme Court and Federal Circuit: Ten Significant Cases in 2013Speaker: J. Peter Fasse
View Description

Past Seminar Topics
For copies of past presentations, please contact Ellen Makarevich at makarevich@fr.com.

2013
Claiming Biological Inventions Post-Myriad: A “Myriad” of Strategies
Are Pharma Sales Made Prior to Patent Invalidation Subject to False Claims Act Suits?
Patent Reform 2013: The New Rules and Portfolio Management Strategies (Two Parts)
Biotech and Pharma Patents at the Federal Circuit: 2012 Year in Review

2012
The USPTO Grapples with Mayo v. Prometheus
New Post-Issuance Procedures for Challenging Patent Validity
Patents 101: A Primer
Mayo v. Prometheus: Where Do We Go from Here?
The European Perspective — Parsing the Patent Landscape
Biotech and Pharmaceutical Patents at the Federal Circuit: 2011 Year in Review

2011
What types of Medical and Diagnostic Method Claims are Patent-eligible?
The “American Invests Act:” What you Need to Know
Patents 101: A Primer
Making Sense of Therasense: What You Need To Know About Inequitable Conduct Today
Recent Developments in Patent Term Adjustment Practice and Strategies for Maximizing PTA
Pharmaceutical Trademarks: The Ins and Outs of Approval by the USPTO and FDA
Biotech and Pharmaceutical Patents at the Federal Circuit: 2010 Year in Review

2010
The Alchemy of Personalized Medicine: Turning Biomarkers into Gold (Two Parts)

Stay current with Fish Sign up for our Newsletter